FindTrial
Sign In

A prospective randomized controlled of CO2 laser-assisted sclerectomy surgery for the treatment of open angle glaucoma

Prospective controlled study of CO2 laser-assisted sclerectomy surgery versus viscocanalostomy for the treatment of primary congenital glaucoma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035651
Enrollment
Unknown
Registered
2020-08-15
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Interventions

Group 1:CLASS
Group 2:viscocanalostomy

Sponsors

The First Affiliated Hospital of Nanjing Medical University (Jiangsu Province Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients with open-angle glaucoma from the age of 18 to 70 years.

Exclusion criteria

Exclusion criteria: 1. Patients with secondary glaucoma; 2. Patients with a history of eye surgery; 3. Patients with combined cataract surgery; 4. Patients with other systemic diseases not suitable for surgery.

Design outcomes

Primary

MeasureTime frame
intraocular pressure;visual acuity;the number of IOP-lowering medications;—

Countries

China

Contacts

Public ContactYuan Zhilan

Department of Ophthalmology, Jiangsu Province Hospital

liangliangyaya@126.com+86 13327813333

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026